| Literature DB >> 19325938 |
Dyonne T Hartong1, Terri L McGee, Michael A Sandberg, Eliot L Berson, Folkert W Asselbergs, Pim van der Harst, Immaculata De Vivo, Thaddeus P Dryja.
Abstract
PURPOSE: Great variation exists in the age of onset of symptoms and the severity of disease at a given age in patients with retinitis pigmentosa (RP). The final pathway for this disease may involve apoptotic photoreceptor cell death. Telomere length is associated with biologic aging, senescence, and apoptosis. We evaluated whether the length of telomeres in leukocytes correlated with the severity of RP in patients with the Pro23His rhodopsin mutation who have shown marked heterogeneity in disease severity.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19325938 PMCID: PMC2661004
Source DB: PubMed Journal: Mol Vis ISSN: 1090-0535 Impact factor: 2.367
Patients included in high and low ERG amplitude groups.
| 218–288 | 5938 | 218–289 | f | 34 | 81 | 0.430198 |
| 001–191 | 1566 | - | m | 38 | 76.0* | 0.537613 |
| 218–289 | 5938 | 218–288 | m | 41 | 69.5 | 0.557743 |
| 226–1070 | 6149 | 226–1063 | m | 49 | 67.5 | 0.364527 |
| 226–1063 | 6149 | 226- 1070 | m | 51 | 51.5 | 0.350156 |
| 226–007 | 5850 | 218–005, 218–002 | f | 56 | 50 | 0.756707 |
| 218–309 | 6281 | - | f | 46 | 46 | 0.376173 |
| 226–685 | 5970 | 001–299 | m | 56 | 42.5 | 0.397979 |
| 001–299 | 5970 | 226–285 | m | 58 | 41.1 | 0.341629 |
| 226–638 | 6149 | - | f | 27 | 41 | 0.380276 |
| 218–243 | 6038 | 226–905 | m | 52 | 38 | 0.394993 |
| 226–905 | 6038 | 218–243 | f | 50 | 38 | 0.556106 |
| 001–385 | 6803 | - | m | 46 | 35.3 | 0.519532 |
| 218–282 | 5938 | - | m | 47 | 27.5 | 0.56872 |
| 218–280 | E716 | - | f | 49 | 12.6 | 0.311241 |
| 001–007 | 6994 | - | f | 34 | 2.3 | 0.364527 |
| 226–1426 | 5998 | - | f | 42 | 1.04 | 0.769996 |
| 001–162 | 6653 | - | f | 46 | 0.7 | 0.368992 |
| 218–003 | 5850 | - | m | 38 | 0.65 | 0.412048 |
| 001–390 | 1509 | - | m | 48 | 0.47 | 0.376173 |
| 218–005 | 5850 | 226–007, 218–002 | m | 55 | 0.3 | 0.608039 |
| 001–131 | 6281 | - | m | 43 | 0.3 | 0.355099 |
| 218–255 | 5938 | 001–387, 218–031 | f | 32 | 0.23 | 0.586807 |
| 001–089 | 6149 | - | f | 31 | 0.2* | 0.799895 |
| 218–407 | 6888 | - | f | 62 | 0.17 | 0.274106 |
| 218–060 | 1566 | - | f | 62 | 0.16 | 0.340283 |
| 001–078 | 6038 | - | m | 49 | 0.15 | 0.197481 |
| 001–387 | 5938 | 218–255, 218–031 | m | 34 | 0.13* | 0.651994 |
| 218–002 | 5850 | 226–007, 218–005 | m | 60 | 0.12 | 0.430762 |
| 218–031 | 5938 | 218–255, 001–387 | m | 41 | 0.08 | 0.638473 |
This table lists the 30 Hz cone ERG amplitudes averaged across both eyes (Av30Hz ERG) for the 15 patients included in the high ERG amplitude group (least severely affected) and the 15 patients included in the low ERG amplitude group (most severely affected) along with the relative telomere lengths (ie. T/S ratio) obtained for each patient, the patient’s age at phlebotomy, their gender and any first degree relatives also included in this study. Age ranges, gender distribution and T/S ratios were similar between the two groups whereas the 30 Hz ERG amplitudes were on average nearly 100 fold greater in the high ERG group than the low ERG group. Amplitudes marked with an * indicate that data was available for only one eye. All patients had reduced or nondetectable rod ERG amplitudes (data not shown); some still had normal cone ERG amplitudes (normal range=50–125 μV).
Figure 1Relative telomere lengths in Pro23His RP patients. Boxplot showing no difference in T:S ratio’s between patients with high- or low ERG amplitudes. The shaded boxes indicate the interquartile range. The horizontal line in each shaded box denotes the median, and the error bars mark the upper and lower 95 percentiles of the T:S ratio.